Back
Bright Minds Biosciences 10K Form
Sell
33
DRUG.CX
Bright Minds Biosciences
Last Price:
53.33
Seasonality Move:
-19.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DRUG.CX News And Ratings
See the #1 stock for the next 7 days that we like better than DRUG.CX
DRUG.CX Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $240.2K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.37 |
| Price / Book: | 39.03 |
Profitability
| EPS (TTM): | -0.92000 |
|---|---|
| Net Income (TTM): | $-3.56M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Bright Minds Biosciences Earnings Forecast
Key Bright Minds Biosciences Financial Ratios
- Per Share Earnings over the last 4 years have been positive in 1 years.
Bright Minds Biosciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | CNSX |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | DRUG.CX |
| Website: | brightmindsbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DRUG.CX Technical Analysis vs Fundamental Analysis
Sell
33
Bright Minds Biosciences (DRUG.CX)
is a Sell
Is Bright Minds Biosciences a Buy or a Sell?
-
Bright Minds Biosciences stock is rated a Sell
The current Bright Minds Biosciences [DRUG.CX] share price is $53.33. The Score for DRUG.CX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.